跳至主導覽 跳至搜尋 跳過主要內容

AI virtual cells for drug discovery and pharmacology

  • Macao Polytechnic University
  • Chinese Academy of Medical Sciences
  • National University of Singapore
  • Chengdu University of Traditional Chinese Medicine

研究成果: Review article › 同儕審查

摘要

Drug discovery relies on cellular assays to determine whether a candidate produces a desired response, reveals its mechanism, or causes toxicity, but only a small fraction of compound–dose–time–context combinations can be measured experimentally. Recent perturbation atlases, single-cell and imaging technologies, and intervention-conditioned AI models now make prediction of unmeasured cellular responses a testable objective. AI virtual cells could therefore complement conventional discovery by prioritizing compounds, contexts, and follow-up experiments rather than replacing laboratory assays. Here, we review the resources and modeling advances supporting this capability, assess their value for mechanism-of-action analysis, efficacy, safety, resistance, and combination studies, and define evidence requirements for pharmacological use. Data coverage makes oncology, including immuno-oncology, plausible early proving grounds, with safety assessment as a crosscutting use case; broader deployment requires perturbation-specific, mechanistic, and decision-level validation.

原文English
頁(從 - 到)1085-1098
頁數14
期刊Trends in Pharmacological Sciences
卷47
發行號10
DOIs
出版品狀態Published - 10月 2026

指紋

深入研究「AI virtual cells for drug discovery and pharmacology」主題。共同形成了獨特的指紋。

引用此